Form 4 for CDNA CareDx, Inc.
Accepted 2025-09-12 00:00:00 ET · period of report 2025-09-11 · accession 0001415889-25-024408 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-12 | 2025-09-11 | CDNA | Bickerstaff George | Dir | M - OptEx | $7.96 | +29.1K | 144.3K | +25% | +$231.9K |
| D | 2025-09-12 | 2025-09-11 | CDNA | Bickerstaff George | Dir | M - OptEx | $0.00 | -29.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-11 | M | A | 29,136 | $7.96 | 144,266 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2025-09-11 | M | D | 29,136 | $0.00 | 0 | D | $7.96 · — to 2033-06-16 | 29,136 Common Stock | (F1) Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on June 16, 2024. |